Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244619 · ClinicalTrials.gov registry record · Phase 4
PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement
A Phase 4 study of Post-op Pain, sponsored by Kettering Health Network.
- Completed
- Registry status
- Phase 4
- Development phase
- 515
- Enrollment target
- 1
- Study location
NCT02244619: Completed Phase 4 study of Post-op Pain, sponsored by Kettering Health Network.
NCT02244619 is a Phase 4 study of Post-op Pain that has completed, run by Kettering Health Network. The registered enrollment target is 515 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02244619, a Phase 4 study of Post-op Pain, has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 515 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen
Primary Outcome
Post-operative use of opioids, measured in morphine milligram equivalent (MME) units
Conditions Studied
Interventions
- DRUG IV acetaminophen
- DRUG Oral acetaminophen
Study Locations (1)
Ohio
- Kettering Medical Center - Kettering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
What the finished NCT02244619 record still lists
NCT02244619 is an interventional study that assigns participants to a tested intervention. The registered 515 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 1 condition, with Post-op Pain appearing as the primary indexed condition, and to 2 interventions - of which IV acetaminophen is the first listed.
NCT02244619 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02244619 about?
NCT02244619 is a clinical study titled "PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement". The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen
What is the current status of trial NCT02244619?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 515 participants. The study started on 2014-09. Estimated completion is 2016-04.
What conditions does trial NCT02244619 study?
This clinical trial studies the following conditions: Post-op Pain.
What interventions are being tested in trial NCT02244619?
The interventions under investigation include: IV acetaminophen (DRUG), Oral acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02244619?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02244619 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-op Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02244619's enrollment target sits among peer trials
515 160th of 2000 higher than 1,841 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia